Evidence map›Paper›PMID 19279089›Full record

ArticleJournal of virology2009

The marmoset model of GB virus B infections: adaptation to host phenotypic variation.

Trudie Weatherford, Deborah Chavez, Kathleen M Brasky, Robert E Lanford

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Marmosets as models of infectious diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Trudie WeatherfordDepartment of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, TX 78227, USA.
Deborah Chavez
Kathleen M Brasky
Robert E Lanford
Texas Biomedical Research Institute · USThe University of Texas Health Science Center at San Antonio · US

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI DAVIS, MICHAEL DUFF · 1999 to 2011
$79.1M
GBV-B-- A SMALL PRIMATE MODEL FOR HEPATITIS C INFECTIONR01AI049574 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI LANFORD, ROBERT E · 2000 to 2008
$2.5M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR012087 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI VANDEBERG, JOHN L · 1996 to 1996
–
NCRR NIH HHS C06 RR012087NCRR NIH HHS C06 RR 12087NCRR NIH HHS P51 RR013986NCRR NIH HHS P51 RR13986NIAID NIH HHS R01 AI049574NIAID NIH HHS R01 AI49574
6 · The paper itself

Abstract

Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV), and chronic infection frequently progresses to serious liver disease, including cirrhosis and hepatocellular carcinoma. GB virus B (GBV-B), the virus phylogenetically most closely related to HCV, causes hepatitis in tamarins. We have demonstrated the suitability of the tamarin as a host for GBV-B and as a surrogate nonhuman primate model for HCV infection, and we have initiated studies of GBV-B infection in a closely related species, the common marmoset (Callithrix jacchus). Here, we demonstrate that marmosets exhibit two phenotypes upon infection with GBV-B: the susceptible phenotype and the partially resistant phenotype. In addition, we identify changes that may correlate with adaptation of the virus to the partially resistant host. GBV-B was serially passaged five times through 14 marmosets as one lineage and two times through 6 marmosets as a second lineage. Virus adapted to the marmosets and eventually exhibited robust infections in two separate lineages, lineages 1 and 2. A third lineage was initiated with a molecular clone, and again, susceptible and partially resistant phenotypes were observed. Three isolates were fully sequenced (from lineage 1), and 21 nucleotide changes were observed, with six amino acid changes. We speculate that the marmoset partially resistant phenotype may be due to a polymorphism in the marmoset population that affects critical virus-host interactions and that wild-type GBV-B is capable of rapidly adapting to this altered host.

Indexed as

Adaptation, BiologicalAnimalsCallithrixDisease Models, AnimalFlaviviridae InfectionsGB virus BHepatitis, Viral, AnimalPhenotypeRNA, ViralRNA, Viral

Identifiers

PMID19279089
PMCPMC2681958
OpenAlexW1971325813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.